Carbachol


Generic Medicine Info
Contraindications
Acute iritis, anterior uveitis, some forms of secondary glaucoma.
Special Precautions
Patient w/ corneal abrasions, pre-existing retinal disease, acute cardiac failure, HTN, hypotension, recent MI, bronchial asthma, hyperthyroidism, peptic ulcer, GI spasm, urinary tract obstruction, Parkinson's disease. Pregnancy and lactation. Patient Counselling This drug may cause blurred vision and difficulty in dark adaptation, if affected, do not drive or operate machinery esp at night or in poor light.
Adverse Reactions
Transient symptoms of burning, stinging, and irritation of the eye; corneal clouding, persistent bullous keratopathy, post-op iritis, retinal detachment, ciliary spasm, blurred vision, lacrimation, difficulty in dark adaptation, increased pupillary block, vitreous haemorrhages, conjunctival vascular congestion, lens changes, sensitisation of the lids and conjunctiva. Rarely, nausea, vomiting, flushing, sweating, diarrhoea, headache, browache, abdominal pain, bronchial asthma and spasm, pulmonary oedema, GI distress, salivation, urinary frequency, cardiac arrhythmia, bradycardia, peripheral vasodilation leading to hypotension.
Drug Interactions
Decreased effectiveness w/ ophth NSAIDs and cyclopentolate. Enhanced cardiac conduction abnormalities and bronchoconstriction w/ β-blockers. Enhanced AR w/ acetylcholinesterase inhibitors.
ATC Classification
S01EB02 - carbachol ; Belongs to the class of parasympathomimetics. Used in the treatment of glaucoma and miosis.
N07AB01 - carbachol ; Belongs to the class of choline esters. Used as parasympathomimetics.
Disclaimer: This information is independently developed by CIMS based on carbachol from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in